ConvaTec Group PLC ConvaTec appoints two Non-Executive Directors (8439N)
14 August 2017 - 4:00PM
UK Regulatory
TIDMCTEC
RNS Number : 8439N
ConvaTec Group PLC
14 August 2017
ConvaTec appoints two Non-Executive Directors
Reading, United Kingdom (14 August 2017)
ConvaTec Group Plc ("ConvaTec" or "the Company") is pleased to
announce the appointments of Dr Regina Benjamin and Mrs Margaret
Ewing as Non-Executive Directors of the Company, with immediate
effect.
Dr Benjamin was United States Surgeon General from 2009 - 2013
and is currently a Non-Executive Director of Diplomat Pharmacy,
Inc, Kaiser Foundation Hospitals and Health Plan, and Ascension
Hospital System. She is a former Non-Executive Director of Alere,
Inc. From 1992-2004 she served on the board of the Medical
Association of Alabama, and in 1995, Dr Benjamin became the first
Young Physician to be elected to the American Medical Association
Board of Trustees. In 2008, she was Chair of the Federation of
State Medical Licensing Boards. Dr Benjamin is CEO and practising
physician at the Bayou La Batre Rural Health Clinic in Alabama,
which she founded in 1990 and holds an endowed chair in Public
Health Sciences at Xavier University of Louisiana. She will
immediately join the Corporate Responsibility Committee.
Mrs Ewing is currently a Trustee of the Board and Chairman of
the Finance and Audit Committee of Great Ormond Street Hospital
Children's Charity. She is also the Independent External member of
the Audit Committee of the Lawn Tennis Association. Mrs Ewing was
previously a Non-Executive Director of Standard Chartered plc,
Whitbread plc and the Confederation of British Industry and the
Independent External member of the Audit Committee of John Lewis
Partnership plc. She was a corporate finance partner of Deloitte
LLP between 1987 - 1999, returning to Deloitte in 2007 as a senior
partner and retiring from the firm in 2012. During the period 2007
- 2012 Mrs Ewing was Vice Chairman and a member of the firm's
Executive Committee and the Board, Senior Partner of the London
practice and latterly Managing Partner for Public Policy, Quality
and Risk. Mrs Ewing was Group Chief Financial Officer of Trinity
Mirror plc from 2000 - 2002 and of BAA plc from 2002 - 2006. She
was also a Member of the Financial Reporting Review Panel between
2011 - 2014. She will immediately join the Audit and Risk Committee
and Corporate Responsibility Committee.
It was previously announced that Dr Raj Shah would be leaving
the Board of ConvaTec on 8th September 2017 following the reduction
by Nordic Capital of their shareholding in the Company. Dr Ros
Rivaz, who was appointed a Non-Executive Director of the Company on
21st June 2017, will immediately join the Nominations and
Remuneration Committees in place of Dr Shah.
Sir Christopher Gent, Chairman of ConvaTec, commented:
"I am delighted to announce two appointments of individuals who
bring a wealth of experience and knowledge to the Board. Also with
the appointments of Regina and Margaret, we have fulfilled our
promise to shareholders that we would appoint a Board which would
comprise a majority of independent Directors and which would
reflect the requirements and advantages of gender diversity. We
look forward to benefitting from their contribution to the future
success of the Company."
This announcement is made in accordance with Listing Rule
9.6.11R(1).
In accordance with Listing Rule 9.6.13(1), Ms Ewing has
confirmed that she was a director of Standard Chartered plc from
1st November 2012 to 31st January 2014, and Dr Benjamin has
confirmed that she is currently a director of Diplomat Pharmacy,
Inc and was a director of Alere, Inc from 12 December 2013 to 22
July 2015.
In accordance with Listing Rule 9.6.13(2) - (6), Ms Ewing and Dr
Benjamin have advised that they have no details to disclose.
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
investorrelations@convatec.com
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion devices. ConvaTec's
products provide a range of clinical and economic benefits
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn
more about ConvaTec, please visit www.convatecgroup.com where a
copy of this announcement can also be found.
# # #
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASFWFMFFWSELA
(END) Dow Jones Newswires
August 14, 2017 02:00 ET (06:00 GMT)
Convatec (LSE:CTEC)
Historical Stock Chart
From Apr 2024 to May 2024
Convatec (LSE:CTEC)
Historical Stock Chart
From May 2023 to May 2024